Jeesun Yoon
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
From screening to surveillance: integrated prevention of Helicobacter pylori-associated gastric cancer in the Asia-Pacific region.
Journal: The Lancet regional health. Western Pacific
Published: July 12, 2026
Promising New Platforms and Targets in the Management of Gastroesophageal Cancers.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 07, 2026
Systemic treatment strategies for combined hepatocellular-cholangiocarcinoma: current evidence and future direction.
Journal: Journal of liver cancer
Published: February 12, 2026
Prognostic value of imaging-detected immune-related adverse events in biliary tract cancer patients receiving durvalumab-based chemotherapy.
Journal: European radiology
Published: February 01, 2026
Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, multicenter, prospective, randomized controlled trial.
Journal: BMC cancer
Published: October 11, 2025
An evaluation of zanidatamab, a novel, anti-HER2 biparatopic antibody, for the treatment of biliary tract cancer.
Journal: Expert opinion on biological therapy
Published: September 02, 2025
Fadraciclib, a CDK2/CDK9 inhibitor, shows efficacy in biliary tract cancer and synergistic potential with olaparib and JQ1 based on MCL1 expression.
Journal: Cell communication and signaling : CCS
Published: June 13, 2025
Analysis of T Cell Subsets Using Multiplex Immunohistochemistry and Clinical Outcomes of Immune Checkpoint Inhibitors in Advanced Gastric Cancer Patients.
Journal: Cancer research and treatment
Published: April 28, 2025
Open-label, single-arm, phase II trial to investigate the efficacy of sitravatinib plus tislelizumab combination as a second-line treatment for advanced biliary tract cancer.
Journal: Journal of hepatology
Published: March 17, 2025
JPI-547, a Dual Inhibitor of PARP/Tankyrase, Shows Antitumor Activity Against Pancreatic Cancers with Homologous Recombination Repair Deficiency or Wnt-Addiction.
Journal: International journal of biological sciences
Published: March 13, 2025
Therapeutic potential of BOLD-100, a GRP78 inhibitor, enhanced by ATR inhibition in pancreatic ductal adenocarcinoma.
Journal: Cell communication and signaling : CCS
Published: January 02, 2025
YAP as a therapeutic target to reverse trastuzumab resistance.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: December 26, 2024
Last Updated: 09/26/2026